Table 1.
Classification of T-cell lymphomas with primary cutaneous manifestations according to their clinical behavior, frequency and disease-specific 5-year survival. Based on the WHO-EORTC guidelines.1
| Clinical behavior | Frequency (%) | Disease-specific 5-year survival (%) | |
|---|---|---|---|
| Mycosis fungoides | Indolent | 39 | 88 |
| Mycosis fungoides variants | |||
| Folliculotropic mycosis fungoides | Indolent | 5 | 75 |
| Pagetoid reticulosis | Indolent | <1 | 100 |
| Granulomatous slack skin | Indolent | <1 | 100 |
| Sézary syndrome | Aggressive | 2 | 36 |
| Primary Cutaneous CD30+ Lymphoproliferative Disorders | |||
| Primary cutaneous anaplastic large T-cell lymphoma | Indolent | 8 | 95 |
| Lymphomatoid papulosis | Indolent | 12 | 99 |
| Adult T-cell lymphoma/leukemia | Indolent / Aggressive | <1 | NR |
| Subcutaneous panniculitis-like T-cell lymphoma | Indolent | 1 | 87 |
| Extranodal NK/T-cell lymphoma, nasal type | Aggressive | <1 | 16 |
| Chronic active EBV infection | Indolent | <1 | NR |
| Primary cutaneous T-cell lymphoma γ/δ | Aggressive | <1 | 11 |
| Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma | Aggressive | <1 | 31 |
| Primary cutaneous acral CD8+ T-cell lymphoma | Indolent | <1 | 100 |
| Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder | Indolent | 6 | 100 |
| Primary Cutaneous Peripheral T-Cell Lymphoma, NOS | Aggressive | 2 | 15 |
NR, not reported; NOS, not otherwise specified.